CRISPR Therapeutics at Week 8: tight dynamic stop, weak confirmation

CRISPR Therapeutics is at week 8 of a buy signal, with the trade down 14%. The confirmation week closed bearish: the model's discipline points to exiting the position. The dynamic stop is almost at entry level — very tight, adjusted to weekly selling pressure. The stock ranks 89th among the 145 open longs for US stocks, with a signal strength of 59 out of 100.